2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
3Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution[J}. Cancer Res, 1997, 57(22): 5179- 5184.
4Wang HL, Anatelli F, Zhai Q J, et al. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions [J]. Arch Pathol Lab Med, 2008, 132(11): 1723-1728.
9Ibarrola C, Castellano VM, Colina F. Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules[J]. Histopathology, 2004, 44(2): 172-179.
10Sato Y, Harada K, Ikeda H, et al. Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver-a potential mechanism of central scar formation[J]. Hum Pathol, 2009, 40(2): 181-188.
7Hamilton SR, Aaltonen LA. World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon:IARC Press, 2000.
8Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma:new classification and relationship with HCC. Hepatology, 2006,43:515-524.
9Dalle I, Sciot R, De Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology, 2000,36:443-450.
10Parfitt JR, Bella AJ, Izawa JI, et al. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med,2006,130 : 1219-1222.
2Departments of Surgical Oncology (Wu FS, Zhao WH, Ma ZM, Teng LS and Wang M) and General Surgery ( Liang TB and Zheng SS) , First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Survival factors after resection of small hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):379-384. 被引量：5
3Hamilton SR, Aahonen LA. World Health Organization Classification of Tumours: Pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2000.
4Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: Etiological analysis and introduction of a new concept[J]. J Gastroenterol Hepatol, 2001, 16(12):1319-1328.
5Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma[J]. J Hepatol, 2008, 48(1):163-170.
6Gong L, Li YH, Su Q, et al. Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver [J]. Pathology, 2009,41(4):348-355.
7Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining socalled telangiectatic focal nodular hyperplasias of the liver[J].Gastroenterology, 2005,128 (5): 1211-1218.
8Rebouissou S, Amessou M, Couchy G, et al. Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours[J]. Nature, 2009,457 (7226):200- 204.
9Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotypephenotype correlation in hepatocellular adenoma: new classification and relationship with HCC [J]. Hepatology, 2006,43(3):515-524.
10Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a muhicenter analysis of risk factors for rupture and malignancy[J]. Ann Surg Oncol, 2009,16(3): 640- 648.
